Imricor Medical Systems (ASX:IMR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Imricor Medical Systems (ASX:IMR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification of cessation of securities - IMR
Notification regarding unquoted securities - IMR
FDA Completes Review of Third PMA Module
FDA completes major Imricor PMA review with one software deficiency already addressed
Cleansing Notice
Application for quotation of securities - IMR
FDA Accepts Imricor PMA Manufacturing Module
FDA Accepts Imricor's Manufacturing Module in PMA Submission
Release from Voluntary Escrow
Imricor and Philips Launch Commercial iMR Lab Solution
Imricor and Philips launch commercial interventional MR lab solution for cardiac care
Imricor U.S. Commercial Momentum Accelerates
Children’s Medical Center Dallas becomes Imricor’s second U.S. customer, accelerating commercial momentum
1H 2026 Investor Presentation
2026 Q2 Form 10-Q
Imricor Medical Systems reports $25.1M net loss for H1 2026 amid clinical and commercialization investments
Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
Imricor launches U.S. commercial operations with FDA pediatric clearances and clinical progress
Philips Declares Compatibility with Imricor
Philips Declares Compatibility with Imricor's Interventional MR Products
Q2 FY26 Results Webinar Notification
Imricor Launches U.S. Commercial Operations
Imricor launches U.S. commercial operations with first customer Rady Children’s Hospital
Imricor Submits All Remaining 510(k) Devices to FDA
Imricor submits final 510(k) devices for FDA clearance, nearing full U.S. market platform
